Skip to main content

Table 2 Validated and novel patient reported outcome measures assessed during the Hypo COMPaSS trial

From: Comparison of Optimised MDI versus Pumps with or without Sensors in Severe Hypoglycaemia (the Hypo COMPaSS trial)

Validated PRO measures

Novel PRO measures undergoing validation

• The Gold Score [44]

• The Hypoglycaemia Awareness Questionnaire (HypoA-Q)*

• The Edinburgh Hypoglycaemia Survey [54]

• The Hypoglycaemia Burden Questionnaire (HypoB-Q)* – part A only

• Clarke Hypoglycaemia Awareness Questionnaire (minimally modified version)

• The Hypoglycaemia Fear Survey II (HFS II) [55]

• The Hypoglycaemia Cues Questionnaires (HypoC-Q)*

• The Hyperglycaemia Avoidance Scale [56]

• The Blood Glucose Monitoring Questionnaire (BGM-Q)*

• The Diabetes Treatment Satisfaction Questionnaire – status version (DTSQ(s)) [57]

• The Quality of Life Questionnaire Diabetes (QoL-Q Diabetes)^

• Insulin Treatment Satisfaction Questionnaire [58] – abridged version including two subscales only

• The Attitudes to Awareness of Hypos Questionnaire#

• EuroQoL EQ-5D [59]

 

• Perceived Control of Diabetes scales (type 1) [60]

 
  1. * designed by Prof Jane Speight and Dr Shalleen Barendse (© AHP Research, 2010).
  2. ^ designed by Prof Jane Speight, Dr Alison Woodcock and Matthew Reaney (© AHP Research, 2007).
  3. # designed by Dr Nicole DeSoyza, Helen Rogers and Prof Stephanie Amiel (King’s College London).